RAD9A and prostate carcinoma: The expression of the AGR2 protein in the prostate cancer cell line PC-3 was shown to be controlled by RAD9A through its specific binding to the 5ʹ-untranslated region of AGR2, and the knockdown of RAD9A resulted in the downregulation of AGR2 [78].